T1	Entity 151 155	5p12
T2	SNP 156 166	rs10941679
R1	SNP_location Arg1:T2 Arg2:T1	
T3	Association 188 198	associated
E1	Association:T3 bc:T4 bc2:T8 snp_int:T2
T4	Cancer 212 225	breast cancer
T5	Entity 240 257	estrogen receptor
T6	Entity 259 261	ER
R2	Equiv Arg1:T6 Arg2:T5	
T7	Effect_Type 263 271	positive
T8	Cancer 240 279	estrogen receptor (ER)-positive disease
A2	Cancer_Type T8 ER+
T9	Organic_inorganic_molecules_affected 188 198	associated
E2	Organic_inorganic_molecules_affected:T9 Agent:T2 Theme:T5
A3	Effect_Type E2 Increase
R3	Effect_type_marker Arg1:E2 Arg2:T7	
T10	Entity 760 775	white Europeans
T11	Association 781 794	per-allele OR
E3	Association:T11 snp_int:T12 bc:T14 bc2:T17
T12	SNP 816 826	rs10941679
T13	Entity 811 815	5p12
R4	SNP_location Arg1:T12 Arg2:T13	
R5	Population_assignment Arg1:T12 Arg2:T10	
T14	Cancer 878 900	invasive breast cancer
A4	Cancer_Type T14 Invasive_NST_ILC_IDC
T15	Entity 878 886	invasive
T16	Patho_physiology 878 886	invasive
E4	Patho_physiology:T16 Theme:T15 Agent:T12
T17	Cancer 945 949	DCIS
A5	Cancer_Type T17 In_Situ
T18	Cell_types_tissues_affected 781 794	per-allele OR
E5	Cell_types_tissues_affected:T18 Theme:T19 Agent:T12
T19	Entity 945 946	D
T20	Entity 955 966	Asian women
T21	Patho_physiology 989 997	invasive
E6	Patho_physiology:T21 Agent:T25 Theme:T22
T22	Entity 989 997	invasive
T23	Association 972 984	estimated OR
E7	Association:T23 bc:T24 snp_int:T25
T24	Cancer 989 1005	invasive disease
A6	Cancer_Type T24 Invasive_NST_ILC_IDC
T25	SNP 816 826	rs10941679
R6	Population_assignment Arg1:T25 Arg2:T20	
R7	SNP_location Arg1:T25 Arg2:T13	
T26	Association 1096 1107	association
E8	Association:T26 bc:T30 snp_int:T12
T27	Entity 1150 1171	progesterone receptor
T28	Entity 1173 1175	PR
R8	Equiv Arg1:T27 Arg2:T28	
T29	Effect_Type 1177 1185	positive
T30	Cancer 1150 1193	progesterone receptor (PR)-positive disease
A7	Cancer_Type T30 PR+
T31	Organic_inorganic_molecules_affected 1096 1107	association
E9	Organic_inorganic_molecules_affected:T31 Theme:T27 Agent:T12
R9	Effect_type_marker Arg1:E9 Arg2:T29	
A8	Effect_Type E9 Increase
T32	Spec 1077 1086	suggested
R10	Speculation_marker Arg1:E8 Arg2:T32	
R11	Speculation_marker Arg1:E9 Arg2:T32	
T33	Level 1466 1474	stronger
T34	Cancer 1479 1497	lower grade tumors
A9	Cancer_Type T34 Other
T35	Association 1445 1456	association
E10	Association:T35 bc:T34 snp_int:T12
A10	Level E10 High
R12	Level_marker Arg1:E10 Arg2:T33	
T36	Cancer 493 517	ductal carcinoma in situ
A1	Cancer_Type T36 In_Situ
R13	Equiv Arg1:T17 Arg2:T36	
T37	Association 1353 1366	heterogeneity
E11	Association:T37 bc:T39 bc2:T38 snp_int:T12
T38	Cancer 1370 1379	ER status
A11	Cancer_Type T38 ER+
T39	Cancer 1370 1379	ER status
A12	Cancer_Type T39 ER-
T40	Neg 1384 1387	not
R14	Negation_marker Arg1:E11 Arg2:T40	
T41	Organic_inorganic_molecules_affected 1353 1366	heterogeneity
E12	Organic_inorganic_molecules_affected:T41 Agent:T12 Theme:T42
T42	Entity 1370 1372	ER
R15	Negation_marker Arg1:E12 Arg2:T40	
T43	Cancer 1491 1497;1585 1604	tumors grade 1, 2, and 3/4
A13	Cancer_Type T43 Other
E13	Association:T35 bc:T43 snp_int:T12
